Healthcare provider profile · identity verified

Kevin Hanigan, D.O.

Family Practice · ANKENY, IA · NPI 1972980902

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	739	219
Lisinopril	Lisinopril	415	136
Amlodipine Besylate	Amlodipine Besylate	374	123
Omeprazole	Omeprazole	367	96
Levothyroxine Sodium	Levothyroxine Sodium	356	93
Simvastatin	Simvastatin	283	98
Metformin Hcl Er	Metformin Hcl	244	69
Rosuvastatin Calcium	Rosuvastatin Calcium	239	63
Losartan Potassium	Losartan Potassium	217	73
Metoprolol Succinate	Metoprolol Succinate	168	55
Tamsulosin Hcl	Tamsulosin Hcl	161	54
Pantoprazole Sodium	Pantoprazole Sodium	158	49
Gabapentin	Gabapentin	152	50
Hydrochlorothiazide	Hydrochlorothiazide	145	55
Metformin Hcl	Metformin Hcl	130	42
Glipizide Er	Glipizide	125	40
Sertraline Hcl	Sertraline Hcl	121	35
Potassium Chloride	Potassium Chloride	106	32
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	104	32
Eliquis	Apixaban	100	24
Albuterol Sulfate Hfa	Albuterol Sulfate	99	37
Furosemide	Furosemide	98	33
Tramadol Hcl	Tramadol Hcl	91	26
Montelukast Sodium	Montelukast Sodium	83	21
Fluticasone Propionate	Fluticasone Propionate	79	22
Escitalopram Oxalate	Escitalopram Oxalate	76	28
Trazodone Hcl	Trazodone Hcl	74	23
Tizanidine Hcl	Tizanidine Hcl	73	22
Benazepril Hcl	Benazepril Hcl	71	21
Nabumetone	Nabumetone	71	15
Pravastatin Sodium	Pravastatin Sodium	71	20
Prednisone	Prednisone	71	47
Allopurinol	Allopurinol	69	23
Glimepiride	Glimepiride	69	24
Metoprolol Tartrate	Metoprolol Tartrate	69	27
Famotidine	Famotidine	66	25
Warfarin Sodium	Warfarin Sodium	64	14
Jardiance	Empagliflozin	61	20
Atenolol	Atenolol	60	17
Cephalexin	Cephalexin	60	44
Finasteride	Finasteride	58	15
Meloxicam	Meloxicam	57	26
Ozempic	Semaglutide	56	11
Alendronate Sodium	Alendronate Sodium	52	16
Citalopram Hbr	Citalopram Hydrobromide	52	12
Fenofibrate	Fenofibrate	50	13
Alprazolam	Alprazolam	42	11
Diclofenac Sodium	Diclofenac Sodium	42	16
Olmesartan Medoxomil	Olmesartan Medoxomil	41	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	35
Januvia	Sitagliptin Phosphate	39	12
Carvedilol	Carvedilol	37	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	37	11
Mirtazapine	Mirtazapine	37	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	22
Bupropion Xl	Bupropion Hcl	34	11
Duloxetine Hcl	Duloxetine Hcl	32	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Clopidogrel	Clopidogrel Bisulfate	31	suppressed
Clonazepam	Clonazepam	30	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	30	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Buspirone Hcl	Buspirone Hcl	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	28	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	27	suppressed
Azithromycin	Azithromycin	26	23
Carbamazepine	Carbamazepine	26	suppressed
Ezetimibe	Ezetimibe	26	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	15
Clonidine Hcl	Clonidine Hcl	25	suppressed
Mounjaro	Tirzepatide	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Eszopiclone	Eszopiclone	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	22
Naproxen	Naproxen	23	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Mupirocin	Mupirocin	22	18
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	suppressed
Novolog Flexpen	Insulin Aspart	22	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	21	suppressed
Baclofen	Baclofen	21	suppressed
Celecoxib	Celecoxib	21	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Fluconazole	Fluconazole	21	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Sildenafil Citrate	Sildenafil Citrate	21	suppressed
Amoxicillin	Amoxicillin	20	19
Bumetanide	Bumetanide	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Lorazepam	Lorazepam	18	suppressed
Ondansetron Odt	Ondansetron	18	15
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Primidone	Primidone	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Invokana	Canagliflozin	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error